RISK OF EARLY AND LATE CARDIOTOXICITY IN DOXORUBICIN-TREATED BREAST-CANCER PATIENTS

被引：0
|
作者：
BUZDAR, A [1 ]
SMITH, T [1 ]
MARCUS, C [1 ]
BLUMENSCHEIN, G [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1983年 / 3卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [11] Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
    Ky, Bonnie
    Putt, Mary
    Sawaya, Heloisa
    French, Benjamin
    Januzzi, James L., Jr.
    Sebag, Igal A.
    Plana, Juan Carlos
    Cohen, Victor
    Banchs, Jose
    Carver, Joseph R.
    Wiegers, Susan E.
    Martin, Randolph P.
    Picard, Michael H.
    Gerszten, Robert E.
    Halpern, Elkan F.
    Passeri, Jonathan
    Kuter, Irene
    Scherrer-Crosbie, Marielle
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (08) : 809 - 816
  • [12] Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin
    Lee, Myunhee
    Chung, Woo-Baek
    Lee, Ji-eun
    Park, Chan-Seok
    Park, Woo-Chan
    Song, Byung-Joo
    Youn, Ho-Joong
    CANCER MEDICINE, 2021, 10 (12): : 3964 - 3973
  • [13] CARDIOPROTECTION WITH ICRF-187 (CARDIOXANE) IN PATIENTS WITH ADVANCED BREAST-CANCER HAVING CARDIAC RISK-FACTORS FOR DOXORUBICIN CARDIOTOXICITY, TREATED WITH THE FDC REGIMEN
    JELIC, S
    RADULOVIC, S
    NESKOVICKONSTANTINOVIC, Z
    KREACIC, M
    RISTOVIC, Z
    BOSNJAK, S
    MILANOVIC, N
    VULETIC, L
    SUPPORTIVE CARE IN CANCER, 1995, 3 (03) : 176 - 182
  • [14] CARDIOTOXICITY EVALUATION IN PATIENTS TREATED WITH A MITOXANTRONE COMBINATION AS ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    FOUNTZILAS, G
    AFTHONIDIS, D
    GELERIS, P
    SALEM, N
    KOTTAS, G
    HALKIDIS, C
    APOSTOLIDIS, P
    BEER, M
    TOURKANTONIS, A
    ANTICANCER RESEARCH, 1992, 12 (01) : 231 - 234
  • [15] CHRONOPHARMACOKINETICS OF DOXORUBICIN IN PATIENTS WITH BREAST-CANCER
    CANAL, P
    SQALLI, A
    DEFORNI, M
    CHEVREAU, C
    PUJOL, A
    BUGAT, R
    ROCHE, H
    OUSTRIN, J
    HOUIN, G
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (03) : 287 - 291
  • [16] Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab
    Espinola-Zavaleta, N.
    Luna-Alcala, S.
    Espejel-Guzman, A.
    Lerma, C.
    Leon, P.
    Guerra, E. C.
    Espinoza Fernandez, J. R.
    Martinez-Dominguez, P.
    Serrano-Roman, J.
    Cabello-Ganem, A.
    Aparicio-Ortiz, A. D.
    Keirns, C.
    Lerma, A.
    Santa Ana-Bayona, M. J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [17] Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab
    Luna-Alcala, Santiago
    Espejel-Guzman, Adrian
    Lerma, Claudia
    Leon, Paula
    Guerra, Enrique C.
    Espinosa Fernandez, Jose Rodrigo
    Martinez-Dominguez, Pavel
    Serrano-Roman, Javier
    Cabello-Ganem, Aldo
    Aparicio-Ortiz, Alexis D.
    Keirns, Candace
    Lerma, Abel
    Santa Ana-Bayona, Maria Jose
    Espinola-Zavaleta, Nilda
    CARDIO-ONCOLOGY, 2024, 10 (01)
  • [18] Cardiotoxicity among patients with breast cancer treated with doxorubicin: A real-world database study
    Manohar, Poorni
    Linden, Hannah M.
    Hess, Lisa M.
    Sugihara, Tomoko
    Zhu, Yajun E.
    Muntz, Howard G.
    Cranmer, Lee D.
    CANCER RESEARCH, 2021, 81 (04)
  • [19] Ventricular-Vascular Coupling Predicts Cardiotoxicity in Breast Cancer Patients Treated With Doxorubicin or Trastuzumab
    Murthy, Ashwin
    Alpert, Craig
    Luo, Lola
    French, Benjamin
    Plappert, Ted
    Khan, Abigail
    Sutton, Martin St John
    Clark, Amy
    Gogineni, Keerthi
    Fox, Kevin
    Domchek, Susan
    DeMichele, Angela
    Carver, Joseph R.
    Ky, Bonnie
    CIRCULATION, 2013, 128 (22)
  • [20] Diastolic dysfunction in patients treated with doxorubicin for early stage breast cancer
    Caram, Megan Veresh
    Leja, Monika
    Smerage, Jeffrey B.
    Guo, Cui
    Griggs, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345